deltatrials
Completed NA INTERVENTIONAL 1-arm NCT02528500

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms (TAMBE)

Early Feasibility Assessment of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms Involving the Visceral Branch Vessels

Sponsor: W.L.Gore & Associates

Updated 19 times since 2017 Last updated: Jun 7, 2023 Started: Nov 30, 2015 Primary completion: May 31, 2016 Completion: Feb 28, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Thoracoabdominal Aortic Aneurysm, this trial is completed. The trial is conducted by W.L.Gore & Associates and has accumulated 19 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshot~Oct 2017 – ~Feb 2018 · 4 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Aug 2019 · 12 months · monthly snapshot~Aug 2019 – ~Aug 2020 · 12 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Jan 2022 · 2 months · monthly snapshot~Jan 2022 – ~Apr 2022 · 3 months · monthly snapshot~Apr 2022 – ~Feb 2023 · 10 months · monthly snapshot~Feb 2023 – ~Jul 2023 · 5 months · monthly snapshot~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

19 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jul 2023 — Jul 2024 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

  5. Feb 2023 — Jul 2023 [monthly]

    Active Not Recruiting NA

Show 14 earlier versions
  1. Apr 2022 — Feb 2023 [monthly]

    Active Not Recruiting NA

  2. Jan 2022 — Apr 2022 [monthly]

    Active Not Recruiting NA

  3. Nov 2021 — Jan 2022 [monthly]

    Active Not Recruiting NA

  4. Oct 2021 — Nov 2021 [monthly]

    Active Not Recruiting NA

  5. Sep 2021 — Oct 2021 [monthly]

    Active Not Recruiting NA

  6. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting NA

  7. Aug 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  8. Aug 2019 — Aug 2020 [monthly]

    Active Not Recruiting NA

  9. Aug 2018 — Aug 2019 [monthly]

    Active Not Recruiting NA

  10. Jun 2018 — Aug 2018 [monthly]

    Active Not Recruiting NA

  11. Feb 2018 — Jun 2018 [monthly]

    Active Not Recruiting NA

  12. Oct 2017 — Feb 2018 [monthly]

    Active Not Recruiting NA

  13. Feb 2017 — Oct 2017 [monthly]

    Active Not Recruiting NA

  14. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting NA

    First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • W.L.Gore & Associates
Data source: W.L.Gore & Associates

For direct contact, visit the study record on ClinicalTrials.gov .